Marksans Pharma Ltd. — Capital/Financing Update 2021

Jul 14, 2021

==> picture [191 x 49] intentionally omitted <==

----- Start of picture text ----- ••Marksans Pharma Ltd.----- End of picture text -----

BSE Limited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai - 40000l. Scrip Code: 524404

National Stock Exchange of India Limited

Listing Department Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS

This is to inform you that the Meeting of the Board of Directors of the Company will be held on Friday, 23[rd] July, 2021, inter alia, to allot convertible warrants on preferential basis as per details given below:

==> picture [454 x 136] intentionally omitted <==

----- Start of picture text ----- Sr. Name of allottee Number of Price per warrants Total value ofNo. warrants INR issue INR1 Mr. Mark Saldanha 10,00,000 74.00 (including 7,40,00,000.00(Promoter) premium of Rs.73.00)2 OrbiMed Asia IV Mauritius 4,93,24,324 74.00 (including 3,64,99,99,976.00FVCILimited premium of Rs.73.00)Total 5,03,24,324 3,7239,999,76.00----- End of picture text -----

Please note that as per the Insider Trading Code of the Company, the Trading Window for dealing in Company's shares is already closed for the Company's insiders.

Yours faithfully,

==> picture [160 x 83] intentionally omitted <==

----- Start of picture text ----- For Marksans Pharma LimitedJ!i-ft(1)J)c _ ~_ pHarshavardhan PanigrahiCompany Secretary----- End of picture text -----

Marksans Pharma Ltd.

11th FI.oor,"GRAND,EUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andhen (W), Mumbal - 400 053 • Tel.: +91 224001 2000 • E-mail: info@marksanspharma.com www.marksanspharma.com